Rosuvastatin Lactone

HCID 29918986CAS 503610-43-3

Grundinformationen

Standard-SMILES
CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H]1C[C@@H](O)CC(=O)O1
InChIKey
SOEGVMSNJOCVHT-VEUZHWNKSA-N
Summenformel
C22H26FN3O5S
Durchschnittliche Molmasse
463,5 g/mol
Monoisotopische Masse
463,15772027

Namen und Bezeichner

Bevorzugter Name
Rosuvastatin Lactone
IUPAC
N-[4-(4-fluorophenyl)-5-[(E)-2-[(2S,4R)-4-hydroxy-6-oxooxan-2-yl]ethenyl]-6-propan-2-ylpyrimidin-2-yl]-N-methylmethanesulfonamide
Englischer Name
N-[4-(4-Fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methylmethanesulfonamide
Summenformel
C22H26FN3O5S
Molmasse
463.52

Namen und Synonyme

Rosuvastatin Lactone503610-43-3Rosuvastatin-5S-lactoneFL37W41F3TDTXSID901034473Methanesulfonamide, N-(4-(4-fluorophenyl)-6-(1-methylethyl)-5-((1E)-2-((2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethenyl)-2-pyrimidinyl)-N-methyl-RefChem:179941DTXCID401519038836-302-1Rosuvastatin EP Impurity DN-[4-(4-Fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methylmethanesulfonamideent-Rosuvastatin Lactone
Weitere Namen anzeigen
Rosuvastatin Impurity DRosuvastatin EP Imp DRsosuvastatin LactoneRosuvastatin calcium-5Rosuvastatin Lactone-d3Rosuvastatin-5R-lactoneRisuvastatin Impurity DRosuvastatin lactone, >=98%
N-(4-(4-fluorophenyl)-5-((E)-2-((2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)vinyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamideN-[4-(4-fluorophenyl)-5-[(E)-2-[(2S,4R)-4-hydroxy-6-oxooxan-2-yl]ethenyl]-6-propan-2-ylpyrimidin-2-yl]-N-methylmethanesulfonamideN-[4-(4-fluorophenyl)-5-[(1E)-2-[(2S,4R)-4-hydroxy-6-oxooxan-2-yl]ethenyl]-6-(propan-2-yl)pyrimidin-2-yl]-N-methylmethanesulfonamideN-[4-(4-fluorophenyl)-5-[(E)-2-[(2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethenyl]-6-(1-methylethyl)pyrimidin-2-yl]-N-methylmethanesulfonamideN-[4-(4-Fluorophenyl)-5-[(E)-2-[(2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethenyl]-6-(1-methylethyl)pyrimidin-2-yl]-N-methylmethanesulfonamide (Rosuvastatin Lactone)N-[4-(4-Fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methylmethanesulfonamide615263-62-2UNII-FL37W41F3T

Datenbank-Bezeichner

CAS
503610-43-3
PubChem CID
29918986
DTXSID
DTXSID901034473
ChEBI
CHEBI:184522
UNII
FL37W41F3T
EC Number
836-302-1
Nikkaji
J2.810.552E

Eigenschaften

Berechnete Struktureigenschaften

XLogP
2,4
Polarare Oberfläche (TPSA)
118 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
9
Frei drehbare Bindungen
6
Schwere Atome
32

Physikochemische Eigenschaften

Schmelzpunkt
131 °C · 131 °C
Siedepunkt
695 · 695.0±65.0 °C(Predicted)
Dichte
1.387 · 1.387
storage temp.
-20 °C · -20°C Freezer
Löslichkeit
Chloroform (Slightly), Methanol (Slightly)
pka
13.22 · 13.22±0.40(Predicted)

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 5 Einträge

Warning

H315 (50%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (50%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (50%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation];H373 (50%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]

P260, P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Gefahrenhinweise

Hazard Classes and CategoriesSkin Irrit. 2 (50%);Eye Irrit. 2 (50%);STOT SE 3 (50%);STOT RE 2 (50%)

Sicherheitsdaten

wgk
WGK 3
Speicherklasse
11 - Combustible Solids
Hazard Classifications
STOT RE 2 Oral

Chemie und Industrie

Pharmakologische Informationen

Tissue LocationsKidney;Liver
Cellular LocationsCytoplasm;Membrane

Anwendungen

VerwendenAn isomer of Rosuvastatin Lactone (R700500); intermediate in the production of Rosuvastatin (R700500) derivatives.

Anbieter50 Anbieter

上海策嵘生物科技有限公司[email protected]
济南百隆化学有限公司[email protected] · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
怀化元研达生物技术有限责任公司18711085600 · [email protected]
广州隽沐生物科技股份有限公司020-36607679; 13502246435 · [email protected]

Zugehörige Reaktionen

4

Verknüpfte Notizen

Wird geladen…